Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sabakem pty ltd - metsulfuron-methyl - water dispersible granule - metsulfuron-methyl urea-sulfonyl active 600.0 g/kg - herbicide - barley | cereal rye | commercial/industrial land | domestic and/or public area | flood plain | natural pasture (native) | pastur - african turnip weed | alligator weed | amsinckia | annual clovers | apple box | australian or native blackthorn | ball mustard | bellyache bush | bitou bush or boneseed | black bindweed | blackberry | blakely's red gum or gum | boggabri weed | bracken | bridal creeper | broadleaf dock | calomba daisy | cape tulip | capeweed | charlock | chickweed | chicory | climbing buckwheat | crofton weed | cutleaf mignonette | darling pea | deadnettle | denseflower fumitory | dock | erodium spp. | fennel | furze or gorse | golden dodder | great mullein | hare's-ear or treacle mustard | harrisia cactus | hawthorn | indian hedge mustard | inkweed | japanese sunflower | kangaroo thorn | lantana - lantana camara | lincoln weed, sand rocket or mustard | mallee catchfly | medic | messmate stringybark | mimosa pigra | mistflower or creeping crofton weed | narrowleaf peppermint | new zealand spinach | noogoora burr | onion or guildford grass | parthenium weed | paterson's curse | prickly lettuce | privet | ragwort | red pigweed (

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - pramipexole dihydrochloride monohydrate - restless legs syndrome; parkinson disease - anti-parkinson drugs - mirapexin is indicated for treatment of the signs and symptoms of idiopathic parkinson's disease, alone (without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end-of-dose or 'on-off' fluctuations).mirapexin is indicated for symptomatic treatment of moderate to severe idiopathic restless-legs syndrome in dosages up to 0.54 mg of base (0.75 mg of salt).

United States - English - NLM (National Library of Medicine)

daiichi sankyo, inc. - pexidartinib hydrochloride (unii: ys6wai3xn7) (pexidartinib - unii:6783m2lv5x) - turalio is indicated for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (tgct) associated with severe morbidity or functional limitations and not amenable to improvement with surgery. none. risk summary based on findings from animal studies and its mechanism of action [see clinical pharmacology (12.1)] , turalio may cause embryo-fetal harm when administered to a pregnant woman. the available human data do not establish the presence or absence of major birth defects or miscarriage related to the use of turalio. oral administration of pexidartinib to pregnant animals during the period of organogenesis resulted in malformations, post-implantation loss, and abortion at maternal exposures that were approximately equal to the human exposure at the recommended dose (see data) . advise pregnant women of the potential risk to a fetus. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 1

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - pramipexole - prolonged-release tablet - 0.26 milligram(s) - dopamine agonists; pramipexole

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - pramipexole - prolonged-release tablet - 3.15 milligram(s) - dopamine agonists; pramipexole

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - pramipexole - prolonged-release tablet - 1.05 milligram(s) - dopamine agonists; pramipexole

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - pramipexole - prolonged-release tablet - 0.52 milligram(s) - dopamine agonists; pramipexole

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - pramipexole - tablets - 0.088 milligram - dopamine agonists

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - pramipexole - tablets - 0.18 milligram - dopamine agonists

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - pramipexole - tablets - 0.7 milligram - dopamine agonists